Onconetix Announces 1-for-5 Reverse Stock Split to Maintain Nasdaq Listing

Onconetix Inc. announced a 1-for-5 reverse stock split to maintain Nasdaq listing compliance. The split, effective March 25, 2026, will reduce the number of outstanding shares from approximately 73.7 million to 14.7 million. Fractional shares will be canceled, and holders will receive cash compensation. The ownership percentage of each stockholder will remain unchanged.